Ataxia Related Research Tools

Ataxia is a degenerative disease of the nervous system. It is a clinical manifestation indicating dysfunction of the parts of the nervous system that coordinates movement, such as the cerebellum. Ataxia can have an insidious onset with a chronic and progressive clinical course (e.g. spinocerebellar ataxias of genetic origin) or have an acute onset resulting from cerebellar infarction, hemorrhage, or infection. Ataxia usually manifests as:

Lack of coordination
Trouble eating and swallowing
Slurred speech
Difficulty in walking
Eye movement abnormalities
Deterioration of fine motor skills
Tremors
Gait abnormalities
Heart problems

Fig.1 Mitochondrial pathophysiology in Friedreich's Ataxia.

Ataxia can be a symptom of a multisystemic disorder, and an underlying etiology needs to be investigated. Ongoing discoveries of genetic abnormalities suggest the possible relations to mitochondrial dysfunction, related protein misfolding, abnormal mechanisms of DNA repair, oxidative stress, and abnormalities in cytoskeletal proteins.

Creative Biolabs is committed to promoting neurology disorders’ research and has developed a series of products to study those treatable and reversible etiologies of Ataxia, especially those from potentially life-threatening causes. These products portfolio includes recombinant proteins, antibodies, analytical/diagnostic kits and other small molecules.

Pathways and Genes Related to Ataxia

Super Pathways	Top Affiliating Genes
A Double-Strand Break Repair	XRCC1, TDP1, PNKP, LIG3, FEN1, ATM
TCR Signaling	WASL, WAS, PIK3R5, CACNA1A, ATM, ACTA1
Chks in Checkpoint Regulation	XRCC1, PNKP, LIG3, FEN1, ATM
G-protein Signaling RAC1 in Cellular Process	WASL, WASF1, WAS, PIK3R5, ACTA1
Iron Metabolism in Placenta	TFRC, ACO1
Mitochondrial Iron-sulfur Cluster Biogenesis	LYRM4, FXN

For Research Use Only. Not For Clinical Use.

Target

SLC14A2

CD11b

Ataxin 1

Neuroligin 1

Gemin 2

CD111

APEX1

Nogo A

NR2E3

OPA1

FABP3

CD29

Als2

FTO

LIM Kinase 1

NF2

Neurofilament L

PGP9.5

DDAH2

S100 Beta

Neuroligin 4

Sarcoplasmic Reticulum

Alpha Synuclein

MOG

BNIP1

Kappa Opioid Receptor

Galectin 7

Laminin alpha 4/LAMA4

NDRG1

Amyloid Beta

Vasopressin

GFR